1. Home
  2. CDNA vs DNOW Comparison

CDNA vs DNOW Comparison

Compare CDNA & DNOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

SELL

Current Price

$64.58

Market Cap

2.6B

Sector

Health Care

ML Signal

SELL

Logo NOW Inc.

DNOW

NOW Inc.

SELL

Current Price

$15.39

Market Cap

2.8B

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
CDNA
DNOW
Founded
1998
1862
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.8B
IPO Year
2007
2014

Fundamental Metrics

Financial Performance
Metric
CDNA
DNOW
Price
$64.58
$15.39
Analyst Decision
Buy
Buy
Analyst Count
7
4
Target Price
★ $61.67
$18.75
AVG Volume (30 Days)
1.4M
★ 1.9M
Earning Date
10-29-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 2.13
N/A
Revenue
$48,324,000.00
★ $2,648,000,000.00
Revenue This Year
$30.36
$79.69
Revenue Next Year
$6.23
$6.97
P/E Ratio
$31.29
★ N/A
Revenue Growth
18.93
★ 25.68
52 Week Low
$14.03
$10.94
52 Week High
$72.51
$17.26

Technical Indicators

Market Signals
Indicator
CDNA
DNOW
Relative Strength Index (RSI) 57.22 47.23
Support Level $61.19 $15.24
Resistance Level $72.51 $16.33
Average True Range (ATR) 3.98 0.41
MACD -0.48 -0.06
Stochastic Oscillator 25.72 45.58

Price Performance

Historical Comparison
CDNA
DNOW

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About DNOW NOW Inc.

Dnow Inc is a provider of energy and industrial solutions and a distributor of pipe, valves, and fittings (PVF) and pumps, as well as fabrication, assembly, and testing of process and production equipment. It provides a broad mix of products required to build and maintain essential infrastructure and operating equipment across upstream, midstream, gas utilities, downstream, energy transition, and industrial markets, along with value-added supply chain solutions and technical product expertise supported by digital offerings through its DigitalNOW and MRCGO e-commerce platforms. The company operates mainly under the DNOW and MRC brands and has three reportable segments: the United States, which generates the majority of revenue, Canada, and International.

Share on Social Networks: